Unicycive Therapeutics Inc (UNCY) Shares Up Despite Recent Market Volatility

Unicycive Therapeutics Inc (NASDAQ: UNCY)’s stock price has soared by 8.75 in relation to previous closing price of 1.37. Nevertheless, the company has seen a gain of 2.05% in its stock price over the last five trading days. GlobeNewsWire reported 2024-02-14 that LOS ALTOS, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that two posters related to the Company’s lead product candidate, oxylanthanum carbonate (OLC), will be presented at the National Kidney Foundation Spring Clinical Meeting taking place May 14-18, 2024, in Long Beach, California.

Is It Worth Investing in Unicycive Therapeutics Inc (NASDAQ: UNCY) Right Now?

UNCY has 36-month beta value of 2.65. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for UNCY is 24.99M, and currently, short sellers hold a 0.23% ratio of that float. The average trading volume of UNCY on April 04, 2024 was 347.18K shares.

UNCY’s Market Performance

UNCY stock saw an increase of 2.05% in the past week, with a monthly gain of 1.35% and a quarterly increase of 75.28%. The volatility ratio for the week is 6.55%, and the volatility levels for the last 30 days are 8.57% for Unicycive Therapeutics Inc (UNCY). The simple moving average for the past 20 days is 3.57% for UNCY’s stock, with a 53.83% simple moving average for the past 200 days.

UNCY Trading at 13.33% from the 50-Day Moving Average

After a stumble in the market that brought UNCY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.85% of loss for the given period.

Volatility was left at 8.57%, however, over the last 30 days, the volatility rate increased by 6.55%, as shares sank -2.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +51.88% upper at present.

During the last 5 trading sessions, UNCY rose by +2.26%, which changed the moving average for the period of 200-days by +2.26% in comparison to the 20-day moving average, which settled at $1.4367. In addition, Unicycive Therapeutics Inc saw 71.71% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for UNCY

Current profitability levels for the company are sitting at:

  • -30.78 for the present operating margin
  • 0.58 for the gross margin

The net margin for Unicycive Therapeutics Inc stands at -61.03. The total capital return value is set at 6.21. Equity return is now at value -700.45, with -359.15 for asset returns.

Based on Unicycive Therapeutics Inc (UNCY), the company’s capital structure generated -0.27 points at debt to capital in total, while cash flow to debt ratio is standing at -22.54. The debt to equity ratio resting at -0.21. The interest coverage ratio of the stock is -461.67.

Currently, EBITDA for the company is -20.49 million with net debt to EBITDA at 0.44. When we switch over and look at the enterprise to sales, we see a ratio of 63.81. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.76.

Conclusion

To put it simply, Unicycive Therapeutics Inc (UNCY) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts